CS Paper Radar

Beyond Fixed Acquisition Functions: Temporal Difference Active Learning for Perturbation Discovery

Xudong Zhang, Jianzhe Li, Yitong Tang, Peijie Zhou

cs.LG ·submitted 2026-10-15 16:00 UTC · v2

Abstract

Genetic and drug perturbation screens are important tools for elucidating disease mechanisms and validating therapeutic targets, but experimental costs limit the number of candidates that can be tested. Existing perturbation screening methods typically update the surrogate model with feedback while keeping the acquisition function fixed, limiting their ability to adapt selection to different response landscapes. Experimental feedback reveals current hits and informs subsequent selection by updating candidate predictions, providing a training signal for learning how to select experiments. We formulate budgeted perturbation discovery as a sequential decision problem and propose Temporal Difference Active Learning (TDAL), which learns an acquisition function online through temporal difference learning from a single screening trajectory, accounting for current hits and future discoveries. TDAL uses the Hellinger distance between hit probabilities for unmeasured candidates before and after an experiment to weight successor value, and reuses measured outcomes through leave-batch-out (LBO) to construct virtual transitions and alleviate training data scarcity. Across eight public screens spanning single, double, and triple perturbations under varied experimental configurations, TDAL achieves an average rank of 1.63 among eleven methods and ranks first on four tasks, demonstrating its adaptability across response landscapes.

Comment
41 pages, 8 figures (including appendices)

Closest papers

Nearest neighbours by meaning across the whole index.

Biology-in-the-loop: Amortized Adaptive Hit Discovery in CRISPR Screens

cs.AI q-bio.QMcs.CLq-bio.GN ·2026-09-10 ·Carl Edwards, Edward De Brouwer, Xiner Li, Namkyeong Lee, Ehsan Hajiramezanali +3 more
benchmark similarity 0.69
Abstract

Many biological discovery problems require experiments to be selected sequentially under constrained budgets. CRISPR screening is a prominent example, as exhaustive perturbation testing is often infeasible and candidate perturbations must instead be prioritized over multiple experimental rounds. Despite the importance of this problem, existing benchmarks for adaptive hit discovery remain limited in scale and diversity. Here, we introduce AssayBench-Loop, a large-scale benchmark for adaptive hit discovery comprising 1,389 CRISPR screens across five phenotype categories. Beyond enabling systematic evaluation, its scale makes it possible to learn acquisition strategies across historical experiments. Building on this resource, we introduce AssayLoop, a sequential experimental design framework combining AssayFormer, a transformer-based amortized acquisition policy trained across historical screens to adapt from experimental feedback, with LLM-derived biological priors through an adaptive handoff. In this view, completed experiments become training data for learning how accumulated evidence should guide what to test next, while LLMs provide prior biological knowledge to seed the search. We further introduce AssayLLM, showing that the same principle can be extended directly to an LLM through task-specific post-training. On temporally held-out screens, AssayLoop achieves a 5.67-fold enrichment over random selection and recovers 27.7% of hits after assaying approximately 5% of the candidate library, outperforming existing adaptive-design methods and standalone LLMs, and AssayFormer alone. Performance improves with increasing historical training data and transfers to phenotype categories excluded from training. These results demonstrate the value of learning acquisition policies across historical experiments and combining them with broad biological priors for efficient adaptive hit discovery.

0.38

ScreenShot: A Foundation Model for Few-Shot Combination Drug Screening

cs.LG ·2026-08-12 ·Antoine de Mathelin, Christopher Tosh, Wesley Tansey
code/data similarity 0.69
Abstract

Treating patients with combinations of drugs reduces the risk of resistance to any individual drug. Finding effective combinations is difficult because the large search space makes combinatorial screens prohibitively expensive, time consuming, and often technically infeasible. Predictive models can fill this gap, yet existing methods typically require molecular profiling of each sample and per-cohort training, limiting their applicability when time and tissue are scarce. To address this challenge, we introduce ScreenShot, a hierarchical transformer pretrained on 40 drug screening datasets covering 3,700 drugs and 6,000 biological samples, whose architecture mirrors the nested structure of screening data. Given a few-shot context of observations from a new patient, ScreenShot predicts the response of the sample to combination therapies through in-context learning, operating directly on functional measurements with no fine-tuning and no molecular profiling. On four held-out datasets, ScreenShot outperforms all baselines in both prediction accuracy and identification of selectively effective treatments. ScreenShot's internal representations are directly useful for experimental design: we use them to drive a weighted k-means++ active learning strategy that selects which experiments to run, achieving the same hit detection as uniform screening with a third of the budget. Source code and interactive dashboard: https://github.com/tansey-lab/screenshot.

0.24

PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction

cs.LG q-bio.QM ·2026-08-21 ·Yoshitaka Inoue, Minoh Jeong, Alfred Hero, Rui Kuang, Augustin Luna
similarity 0.66
Abstract

Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction. Existing approaches predict response from pretreatment molecular profiles and drug representations, without explicitly modeling the molecular changes expected under treatment. We propose PerturbRx, a treatment-conditioned representation learning framework that learns intervention-induced latent transitions and uses them as patient-drug response features. PerturbRx trains a drug- and dose-conditioned transition predictor from context-matched but cell-unpaired control and treated single-cell populations, then freezes and transfers the predictor to pretreatment patient profiles without requiring post-treatment measurements. The transition is combined with patient and drug representations to predict response. Across TCGA and patient-derived xenograft benchmarks, PerturbRx achieves the strongest aggregate predictive performance among the evaluated methods. These results support perturbation-pretrained latent transitions as useful representations for patient-level drug-response prediction.

0.25

Few-Shot Bioactivity Prediction with Meta-Learning under Assay Heterogeneity

cs.LG ·2026-10-05 ·Michal Kmicikiewicz, Tommy Rochussen, Vincent Fortuin, Ewa Szczurek
similarity 0.65
Abstract

Accurate bioactivity prediction is a central challenge in early-stage drug discovery, as individual assays often contain too few measurements to train reliable models independently. Meta-learning offers a principled approach to this few-shot setting, but assay heterogeneity may limit its effectiveness. Here, we test this hypothesis and show that meta-learning performance degrades as meta-training tasks become more heterogeneous. To address this, we introduce MetaHeta, a meta-learning framework that accounts for assay heterogeneity by conditioning predictions on auxiliary data from related assays, with relatedness defined flexibly from available assay information. The architecture of MetaHeta combines linear attention over large auxiliary datasets with exact attention over scarce task-specific context, enabling efficient scaling to the former without compromising exact attention over the latter. We demonstrate the benefits of our approach on assays from ChEMBL and BindingDB, improving few-shot bioactivity prediction and downstream compound prioritization in retrospective Bayesian optimization.

0.17

PETA:Parameter-Efficient Test-Time Adaptation for Virtual Screening

cs.LG ·2026-08-20 ·Jia-Qi Lin, Yinghua Yao, Chang-Dong Wang, Yew-Soon Ong, Yuangang Pan
similarity 0.65
Abstract

Accurately ranking active ligands for a target protein pocket from massive chemical libraries remains a central challenge in virtual screening. DrugCLIP and its recent extensions substantially accelerate this process by encoding protein pockets and molecules into a shared embedding space. Despite this progress, further performance improvements typically require retraining the entire model, incurring substantial computational overhead and making target-specific customization inefficient. In this work, we formulate the specialization of pretrained virtual screening models to individual pockets as a test-time adaptation problem and propose PETA, a parameter-efficient framework that directly adapts pretrained model at test time. Given a target pocket, PETA constructs pocket-specific negatives through molecular diffusion and chemical validity filtering, and further moves them toward the reference ligand retrieved from structural databases via embedding-space mixup to create more challenging ranking tasks. A ranking objective then places greater emphasis on suppressing high-scoring invalid candidates that could contaminate the top-ranked screening results, providing structured supervision for lightweight adaptation. Experiments across diverse benchmarks demonstrate that this lightweight, pocket-specific adaptation outperforms both pretrained and fully retrained baselines while updating only the LayerNorm parameters, which account for approximately $0.03\%$ of the full model.

0.16

SciSelect-Gym: An Environment and Benchmark for Active Learning and Bayesian Optimization Configuration Selection

cs.CE ·2026-11-11 ·Ying-Peng Tang, Tianle Zhang, Wanlong Fang, Ng Jing Xiang, Alvin Chan
benchmarkdataset similarity 0.65
Abstract · Under journal review

In many scientific tasks, scientists repeatedly choose a small set of candidates to test, learn from the results, and use the observations to guide the next selection. Methods based on active learning~(AL) or Bayesian optimization~(BO) have been proposed for these iterative screening campaigns with a surrogate model. Yet, selecting the surrogate model and acquisition function for a new dataset remains challenging due to limited empirical evidence, while the effectiveness of large language models (LLMs) in making such decisions remains unclear. To address these gaps, we introduce SciSelect-Gym, an environment for simulating AL/BO data selection campaigns and evaluating configuration choices. We conducted simulations of AL/BO data selection campaigns across several settings and more than 100 molecular datasets. Using completed simulation campaigns as context improves LLM recommendation shortlists on held-out datasets more consistently than it improves the quality of their first choice. SciSelect-Gym provides a simulation platform and recommendation protocols for learning how to choose configurations before an acquisition campaign. An implemented agent use case connects these campaign records and simulation tools to LLM-generated configuration-selection policies. The code is provided as supplementary material.

0.23

AssayRouter: Historical Utility Priors for Frozen Molecular Predictor Routing

cs.AI q-bio.BMq-bio.QM ·2026-09-29 ·Dong Xu, Zhangfan Yang, Jiantao Wu, Shipeng Zhang, Zexuan Zhu +3 more
similarity 0.64
Abstract · 26 pages, 6 figures

Laboratories often face a new molecular assay with 16-64 labels and a bank of predictors whose training data and parameters are unavailable. The practical question is which frozen outputs to include in a small local model. AssayRouter treats completed assays as pseudo-targets and labels each candidate by its post-fit utility: the reduction in held-out discovery loss when the candidate is added to the local target predictor. A shared regressor learns to predict this utility from candidate behavior on the support set, without source identity; on a new assay, one frozen ranking selects four sources and separate labels fit a convex combiner. We train only on completed ChEMBL-MT assays and evaluate 24 external regression assays across six frozen interface families. AssayRouter-C lowers strict four-call negative log-likelihood (NLL) by 0.0409 relative to Support-CV@4. Frozen candidate-label permutations confirm that candidate-utility correspondence carries the transferred information, and leave-one-interface-out training shows that the mapping generalizes to unseen predictor families. Completed assays therefore provide transferable supervision for scarce-label routing through frozen prediction interfaces.

0.53

Soft Strategy Selection for Batch-Mode Active Learning

cs.LG cs.AI ·2026-10-04 ·Rushil Gupta, Romain Lopez
benchmark similarity 0.64
Abstract · Preprint. 36 pages with appendices

Real-world deployment of active learning typically forces practitioners to choose an acquisition strategy before any data is labeled. This is a daunting task: strategy performance varies widely across settings (e.g. datasets, surrogate models) and cannot be assessed without deployment. Existing strategy selection methods explore one strategy from a portfolio at each round and identify the optimal one using bandit feedback or model retraining. Many acquisition rounds are therefore spent exploring strategies rather than collecting the most informative data. Such overhead is a major barrier to AL-driven design of high-throughput experiments, such as genetic perturbation screens and directed evolution, where AL runs consist of only a few rounds with large batch sizes. This regime permits a natural alternative: acquiring data using multiple AL strategies within a single batch. We refer to this as soft strategy selection and introduce FractAL, a method specifically designed for this task. FractAL infers a per-strategy reward using influence-function-based data attribution, which requires no additional retraining, and then computes budget shares for each strategy in the portfolio using online mirror descent. We benchmark FractAL across 7 setups spanning classification, regression, and genetic perturbation effect prediction. The results highlight that strategy selection is a hard problem: every existing method performs worse than random sampling on at least one setup. FractAL, however, matches or outperforms every baseline, including random sampling, on all 7 setups. Its allocations concentrate budget on the strongest strategies in the portfolio while pruning the weakest. FractAL is therefore a reliable choice for real-world deployments, where the optimal strategy is unknown in advance, an important step towards making AL practical for high-throughput experiments and modern scientific discovery.

0.32